Niagen Bioscience, Inc. (NAGE) vs Entrada Therapeutics, Inc. (TRDA)

Niagen Bioscience, Inc. and Entrada Therapeutics, Inc. are both Biotechnology companies. Niagen Bioscience, Inc. and Entrada Therapeutics, Inc. are of similar size ($242.2M and $238.2M). Entrada Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 15.2×. Niagen Bioscience, Inc. grew revenue faster over the last twelve months: 11.0% against −94.1%. Niagen Bioscience, Inc. has the higher net margin (12.4% vs −3,537.7%) and the higher return on invested capital (42.0% vs −1,060.2%). Across the 16 metrics below, Niagen Bioscience, Inc. leads on 13 and Entrada Therapeutics, Inc. on 3.